Psoriasis Group Issues "60 Second Google Challenge" To Congress, USA

Main Category: Eczema / Psoriasis
Also Included In: IT / Internet / E-mail
Article Date: 02 Mar 2005 - 13:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  


Current Article Ratings:

Patient / Public:3 stars

3 (2 votes)

Healthcare Prof:not yet rated

Article Opinions: 2 posts

"Psoriasis Cure Now," a nonprofit patient advocacy group, today challenged more than 1,000 senior Congressional staffers to spend just 60 seconds viewing pictures of psoriasis-affected skin. The stunt is the latest effort by the group to highlight the seriousness of the incurable immune disease and to increase research funding for psoriasis.

More than 1,000 Congressional staffers involved in health issues (as well as more than 1,000 journalists who cover health news) were asked to spend 60 seconds viewing psoriasis pictures at Google.com (or any other internet search engine). The Google images are here: images.google.com/images?q=psoriasis

"They say a picture is worth a thousand words," said Michael Paranzino, president of Psoriasis Cure Now and a psoriasis patient for two decades. "We figured this would be an unconventional, but highly effective, method of demonstrating how devastating psoriasis often is."

Paranzino, a former Congressional staffer, noted that Hill staffers are incredibly busy and that most use Google on a daily basis.

"The volume of written material sent to Congressional offices would make speed reading guru Evelyn Wood blush," Paranzino continued. "By asking key Congressional staff to study psoriasis for a mere 60 seconds on a popular search engine, we hope to break through the clutter and advance our contention that psoriasis research is woefully underfunded."

Federally-funded psoriasis research declined between 1995 and 2004, at the same time research on other diseases at the National Institutes of Health soared a much-needed 148%. Government funding for psoriasis and psoriatic arthritis research now stands at just 77 cents per patient annually, a tiny fraction of the amount spent on most other diseases of comparable severity and impact. There are 6.5 million Americans with psoriasis, more than 1 million of whom also have psoriatic arthritis.

"We are confident that anyone who spends 60 seconds reviewing photos of actual psoriasis patients will agree that the estimated 15,000 constituents with psoriasis in each Congressional District deserve better," Paranzino added.

Psoriasis Cure Now is on the web at http://www.psorcurenow.org . The group has no affiliation with Google.

Media contact:

Michael Paranzino
Psoriasis Cure Now
202-253-4863
michael@psorcurenow.org

Psoriasis Cure Now
P.O. Box 2544
Kensington, MD 20891, USA
(301) 571-2393

Article adapted by Medical News Today from original press release.
Visit our eczema / psoriasis section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Mary Sweeney. "Psoriasis Group Issues "60 Second Google Challenge" To Congress, USA." Medical News Today. MediLexicon, Intl., 2 Mar. 2005. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/20569.php>

APA
Mary Sweeney. (2005, March 2). "Psoriasis Group Issues "60 Second Google Challenge" To Congress, USA." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/20569.php.

Please note: If no author information is provided, the source is cited instead.




Eczema / Psoriasis

What is Psoriasis?

Psoriasis is a chronic autoimmune disease that mainly affects the skin. It is non-contagious. A reddish, scaly rash - often referred to as red, scaly patches - is commonly found over the surfaces of the scalp, around or in the ears, the elbows, knees... Read more...

Most Popular Articles



Follow Our Eczema News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Eczema / Psoriasis Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »